https://m2.mtmt.hu/ hun 2026-09-22 15:42 JournalArticle 33999222 VALIDATED true Funding Agency and Grant Number: Ministry for Innovation and Technology of Hungary; Hungarian Respiratory Society [UNKP-20-3, UNKP-21-3]; IASLC/ILCF Young Investigator Grant [2020]; Semmelweis 250+ Excellence PhD Scholarship by Semmelweis University; Hungarian National Research, Development and Innovation Office [EFOP-3.6.3-VEKOP-16-2017-00009]; Austrian Science Fund [KH130356, K129065, KNN121510]; Breast Cancer Research Foundation [FWF I3977, I4677]; Novo Nordisk Foundation Interdisciplinary Synergy Programme Grant; Hungarian National Research, Development and Innovation Office [NNF15OC0016584]; Hungarian Brain research Program [K129065]; [2017-1.2.1-NKP-2017-00002] Funding text: ZM was supported by the UNKP-20-3 and UNKP-21-3 New National Excellence Program of the Ministry for Innovation and Technology of Hungary and by the Hungarian Respiratory Society (MPA #2020). ZM is also the recipient of the IASLC/ILCF Young Investigator Grant. BF is a recipient of Semmelweis 250+ Excellence PhD Scholarship (EFOP-3.6.3-VEKOP-16-2017-00009) by Semmelweis University. BD acknowledge funding from the Hungarian National Research, Development and Innovation Office (KH130356, K129065, and KNN121510) and the Austrian Science Fund (FWF I3977 and I4677). ZS was supported by the Breast Cancer Research Foundation and the Novo Nordisk Foundation Interdisciplinary Synergy Programme Grant (NNF15OC0016584). JM was supported by the Hungarian National Research, Development and Innovation Office (K129065) and by the Hungarian Brain research Program (grant 2017-1.2.1-NKP-2017-00002). 0 false 2026-07-21T12:39:17.411+0000 2026-01-06T08:31:00.671+0000 2023-06-06T09:23:38.923+0000 true 10070075 Nádas Orsolya /api/admin/10070075 Admin Nádas Orsolya (OOI admin4) true 2026-07-21T12:31:39.992+0000 2026-01-06T08:31:00.967+0000 true 10003134 Wolf György /api/admin/10003134 Admin Wolf György (MTMT Központi admin) true 10003134 Admin 10073918 /api/admin/10073918 Kovács Marcell (MTMT Közp., admin) Kovács Marcell true true 2023-10-04T07:54:51.165+0000 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Gyulai, Marton true true /api/journal/1035680 REVIEWED PATHOLOGY AND ONCOLOGY RESEARCH 1219-4956 1532-2807 true false 1035680 false 1035680 true 1219-4956 1532-2807 Journal FOREIGN_AND_HUNGARIAN 29 1611164 1611164 9 2023 Background: Our knowledge is still limited about the characteristics and treatment of rare lung tumors. The aim of our study was to determine programmed cell death ligand-1 (PD-L1) and programmed cell death-1 (PD-1) expression in rare pulmonary tumors to assess the potential role of immunotherapy. Funding 2027445 /api/funding/2027445 (ÚNKP-20-3) false true Funding 2027446 /api/funding/2027446 (UNKP-21-3) false true Funding 2027447 /api/funding/2027447 (Hungarian Respiratory Society (MPA #2020)) false true Funding 2027448 /api/funding/2027448 Az orvos-, egészségtudományi- és gyógyszerészképzés tudományos műhelyeinek fejlesztése(EFOP-3.6.3-VEKOP-16-2017-00009) Támogató: EFOP-VEKOP false true Funding 2027449 /api/funding/2027449 (KH130356) false true Funding 2027450 /api/funding/2027450 (K129065) false true Funding 2027451 /api/funding/2027451 (KNN121510) false true Funding 2027452 /api/funding/2027452 (K129065) false true Funding 2027453 /api/funding/2027453 (2017-1.2.1-NKP-2017-00002.) false true true INTERNATIONAL 2023 true true true false true false NONE 2026-07-21 false 5 0 5 5 0 5 4 5 4 5 5 5 5 5 0 0 5 5 5 5 0 5 5 Folyóiratcikk Journal Article 24 5 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2023 0 1 1 1 1 2024 0 1 1 1 1 2025 0 2 2 2 2 2026 0 1 1 1 1 Q2 false false false false 2023-06-11T11:34:03.360+0000 Bioinformatika Tanszék (SE / AOK / I); Doktori Iskola (SE); Mellkassebészeti Klinika (SE / AOK / K); Országos Korányi Pulmonológiai Intézet; Országos Onkológiai Intézet; Patológiai és Kísérleti Rákkutató Intézet (SE / AOK / I) 9 33 6 11 0 true 10073918 Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 108891245 /api/authorship/108891245 Gyulai, Marton [Gyulai, Márton (tüdőgyógyászat), szerző] Doktori Iskola (SE) 1 0.091 true false false Author 10088166 /api/author/10088166 Gyulai Márton (tüdőgyógyászat) Gyulai Márton true true Gyulai Marton true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108891246 /api/authorship/108891246 Megyesfalvi, Zsolt [Megyesfalvi, Zsolt (Orvostudomány), szerző] Országos Onkológiai Intézet; Mellkassebészeti Klinika (SE / AOK / K) 2 0.091 false false false Author 10071898 /api/author/10071898 Megyesfalvi Zsolt (Orvostudomány) Megyesfalvi Zsolt true true Megyesfalvi Zsolt true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108891247 /api/authorship/108891247 Reiniger, Lilla [Reiniger, Lilla (Neuropatológia), szerző] Patológiai és Kísérleti Rákkutató Intézet (SE / AOK / I) 3 0.091 false false false Author 10025104 /api/author/10025104 Reiniger Lilla (Neuropatológia) Reiniger Lilla true 10025104 true Reiniger Lilla true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108891248 /api/authorship/108891248 Harko, Tunde 4 0.09090909 false false false Harko Tunde true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108891249 /api/authorship/108891249 Ferencz, Bence [Ferencz, Bence (Patológia), szerző] Országos Onkológiai Intézet; Mellkassebészeti Klinika (SE / AOK / K) 5 0.091 false false false Author 10077112 /api/author/10077112 Ferencz Bence (Patológia) Ferencz Bence true true Ferencz Bence true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108891250 /api/authorship/108891250 Karsko, Luca 6 0.09090909 false false false Karsko Luca true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108891251 /api/authorship/108891251 Agocs, Laszlo [Agócs, László (Mellkassebészet), szerző] Országos Onkológiai Intézet; Mellkassebészeti Klinika (SE / AOK / K) 7 0.091 false false false Author 10051707 /api/author/10051707 Agócs László (Mellkassebészet) Agócs László true 10051707 true Agocs Laszlo true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108891252 /api/authorship/108891252 Fillinger, Janos [Fillinger, János (patológia), szerző] 8 0.09090909 false false false Author 10023823 /api/author/10023823 Fillinger János (patológia) Fillinger János true 10023823 true Fillinger Janos true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108891253 /api/authorship/108891253 Dome, Balazs [Döme, Balázs (Tumor indukált an...), szerző] Országos Onkológiai Intézet; Mellkassebészeti Klinika (SE / AOK / K) 9 0.091 false false false Author 10000046 /api/author/10000046 Döme Balázs (Tumor indukált angiogenezis) Döme Balázs true 10000046 true Dome Balazs true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108891254 /api/authorship/108891254 Szallasi, Zoltan [Szállási, Zoltán (Onkológia, dagana...), szerző] Bioinformatika Tanszék (SE / AOK / I) 10 0.091 false false false Author 10068108 /api/author/10068108 Szállási Zoltán (Onkológia, daganatkutatás) Szállási Zoltán true true Szallasi Zoltan true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108891255 /api/authorship/108891255 Moldvay, Judit ✉ [Moldvay, Judit (Tüdõgyógyászat), szerző] Országos Korányi Pulmonológiai Intézet 11 0.091 false true true Author 10003072 /api/author/10003072 Moldvay Judit (Tüdõgyógyászat) Moldvay Judit true 10003072 true Moldvay Judit true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 23991605 /api/publicationidentifier/23991605 DOI: 10.3389/pore.2023.1611164 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.3389/pore.2023.1611164 https://doi.org/10.3389/pore.2023.1611164 false true PublicationIdentifier 24097348 /api/publicationidentifier/24097348 WoS: 001000102700001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001000102700001 https://www.webofscience.com/wos/woscc/full-record/001000102700001 true true PublicationIdentifier 24021570 /api/publicationidentifier/24021570 Scopus: 85160982518 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85160982518 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85160982518 true true PublicationIdentifier 23991607 /api/publicationidentifier/23991607 PubMed: 37274772 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 37274772 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37274772&dopt=Abstract false true PublicationIdentifier 29836203 /api/publicationidentifier/29836203 Egyéb URL: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85160982518&doi=10.3389%2Fpore.2023.1611164&partnerID=40&md5=efe8ce91e956272954d7fb703d919ae7 PlainSource 40 /api/publicationsource/40 Egyéb URL PublicationSourceType 10006 /api/publicationsourcetype/10006 Link true true true Egyéb URL Other URL @@@ true true 40 true NONE IDENTICAL https://www.scopus.com/inward/record.uri?eid=2-s2.0-85160982518&doi=10.3389%2Fpore.2023.1611164&partnerID=40&md5=efe8ce91e956272954d7fb703d919ae7 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85160982518&doi=10.3389%2Fpore.2023.1611164&partnerID=40&md5=efe8ce91e956272954d7fb703d919ae7 false true Classification 12306 /api/classification/12306 Onkológia true true Classification 12211 /api/classification/12211 Patológia true true SjrRating 11397865 /api/sjrrating/11397865 sjr:Q2 (2023) Scopus - Medicine (miscellaneous) PATHOLOGY AND ONCOLOGY RESEARCH 1219-4956 1532-2807 838 0.49 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2701 /api/classificationexternal/2701 Scopus - Medicine (miscellaneous) true 2701 true Q2 DIRECT true true Reference 42133675 /api/reference/42133675 1. Sung 2021: Global cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries., CA: A Cancer J Clin, 71, p. 209, DOI: 10.3322/caac.21660 1 10.3322/caac.21660 false true Reference 42133676 /api/reference/42133676 2. Shao 2022: A systematic review and network meta-analysis of first-line immune checkpoint inhibitor combination therapies in patients with advanced non-squamous non-small cell lung cancer., Front Immunol, 13, p. 948597, DOI: 10.3389/fimmu.2022.948597 2 10.3389/fimmu.2022.948597 false true Reference 42133677 /api/reference/42133677 3. O'Byrne 2023: Long-term comparative efficacy and safety of nivolumab plus ipilimumab relative to other first-line therapies for advanced non-small-cell lung cancer: A systematic literature review and network meta-analysis., Lung Cancer, 177, p. 11, DOI: 10.1016/j.lungcan.2023.01.006 3 10.1016/j.lungcan.2023.01.006 false true Reference 42133678 /api/reference/42133678 4. Ancevski Hunter 2018: PD-L1 testing in guiding patient selection for PD-1/PD-L1 inhibitor therapy in lung cancer., Mol Diagn Ther, 22, p. 1, DOI: 10.1007/s40291-017-0308-6 4 10.1007/s40291-017-0308-6 false true Reference 42133679 /api/reference/42133679 5. Maule 2022: Comparison of PD-L1 tumor cell expression with 22C3, 28-8, and SP142 IHC assays across multiple tumor types., J Immunother Cancer, 10, p. e005573, DOI: 10.1136/jitc-2022-005573 5 10.1136/jitc-2022-005573 false true Reference 42133680 /api/reference/42133680 6. Pisano 2022: Moving through rare lung cancer histologies: A narrative review on diagnosis and treatment of selected infrequent entities., Precis Cancer Med, 5, p. 27, DOI: 10.21037/pcm-22-4 6 10.21037/pcm-22-4 false true Reference 42133681 /api/reference/42133681 7. Lee 2022: Approaches to the management of metastatic adenoid cystic carcinoma., Cancers (Basel), 14, p. 5698, DOI: 10.3390/cancers14225698 7 10.3390/cancers14225698 false true Reference 42133682 /api/reference/42133682 8. Garg 2019: Primary salivary gland-type tumors of the lung: A systematic review and pooled analysis., Lung India, 36, p. 118, DOI: 10.4103/lungindia.lungindia_284_18 8 10.4103/lungindia.lungindia_284_18 false true Reference 42133683 /api/reference/42133683 9. Zheng 2021: PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasm., Transl Lung Cancer Res, 10, p. 4617, DOI: 10.21037/tlcr-21-958 9 10.21037/tlcr-21-958 false true Reference 42133684 /api/reference/42133684 10. Festino 2016: Cancer treatment with anti-PD-1/PD-L1 agents: Is PD-L1 expression a biomarker for patient selection?., Drugs, 76, p. 925, DOI: 10.1007/s40265-016-0588-x 10 10.1007/s40265-016-0588-x false true Reference 42133685 /api/reference/42133685 11. Yang 2016: Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma., Eur J Cancer, 57, p. 91, DOI: 10.1016/j.ejca.2015.12.033 11 10.1016/j.ejca.2015.12.033 false true Reference 42133686 /api/reference/42133686 12. Téglási 2019: PD-L1 expression of lung cancer cells, unlike infiltrating immune cells, is stable and unaffected by therapy during brain metastasis., Clin Lung Cancer, 20, p. 363, DOI: 10.1016/j.cllc.2019.05.008 12 10.1016/j.cllc.2019.05.008 false true Reference 42133687 /api/reference/42133687 13. Reiniger 2019: Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma., Acta Oncol, 58, p. 1087, DOI: 10.1080/0284186X.2019.1598575 13 10.1080/0284186X.2019.1598575 false true Reference 42133688 /api/reference/42133688 14. Rojkó 2018: Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients., J Cancer Res Clin Oncol, 144, p. 1219, DOI: 10.1007/s00432-018-2642-4 14 10.1007/s00432-018-2642-4 false true Reference 42133689 /api/reference/42133689 15. Téglási 2017: Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis., Neuro Oncol, 19, p. 1058, DOI: 10.1093/neuonc/now309 15 10.1093/neuonc/now309 false true Reference 42133690 /api/reference/42133690 16. Guan 2021: Influence of different age cutoff points on the prediction of prognosis of cancer patients receiving ICIs and potential mechanistic exploration., Front Oncol, 11, p. 670927, DOI: 10.3389/fonc.2021.670927 16 10.3389/fonc.2021.670927 false true Reference 42133691 /api/reference/42133691 17. Li 2022: Low-dose radiotherapy combined with immunotherapy for suboral adenoid cystic carcinoma with bilateral lung metastasis: A case report and literature review., Oncol Lett, 24, p. 279, DOI: 10.3892/ol.2022.13399 17 10.3892/ol.2022.13399 false true Reference 42133692 /api/reference/42133692 18. Farhat 2022: Pembrolizumab as a first line therapy in a patient with extensive mucoepidermoid salivary gland carcinoma. A complete clinical, radiological and pathological response. A very specific case., Discov Oncol, 13, p. 37, DOI: 10.1007/s12672-022-00502-4 18 10.1007/s12672-022-00502-4 false true Reference 42133693 /api/reference/42133693 19. Pharaon 2022: Prolonged response to checkpoint inhibitor therapy in two metastatic mucoepidermoid salivary gland carcinoma cases: A research report., Cold Spring Harb Mol Case Stud, 8, p. a006189, DOI: 10.1101/mcs.a006189 19 10.1101/mcs.a006189 false true Reference 42133694 /api/reference/42133694 20. Mueller 2022: Targeted therapy, chemotherapy, immunotherapy and novel treatment options for different subtypes of salivary gland cancer., J Clin Med, 11, p. 720, DOI: 10.3390/jcm11030720 20 10.3390/jcm11030720 false true Reference 42133695 /api/reference/42133695 21. Hu 2022: Pulmonary salivary gland tumor, mucoepidermoid carcinoma: A literature review., J Oncol, 2022, p. 9742091, DOI: 10.1155/2022/9742091 21 10.1155/2022/9742091 false true Reference 42133696 /api/reference/42133696 22. Liu 2018: Expression of programmed death receptor 1 and its ligand in primary lung mucoepidermoid carcinoma and its clinical significance., Fujian Med J, 40, p. 16 22 false true Reference 42133697 /api/reference/42133697 23. Gerdabi 2022: Simultaneous expression of PD-1 and PD-L1 in peripheral and central immune cells and tumor cells in the benign and malignant salivary gland tumors microenvironment., Head Neck Pathol, 17, p. 178, DOI: 10.1007/s12105-022-01486-x 23 10.1007/s12105-022-01486-x false true Reference 42133698 /api/reference/42133698 24. Witte 2020: Prognostic impact of PD-L1 expression in malignant salivary gland tumors as assessed by established scoring criteria: Tumor proportion score (TPS), combined positivity score (CPS), and immune cell (IC) infiltrate., Cancers, 12, p. 873, DOI: 10.3390/cancers12040873 24 10.3390/cancers12040873 false true Reference 42133699 /api/reference/42133699 25. Xu 2019: The immune microenvironment and expression of PD-L1, PD-1, PRAME and MHC I in salivary duct carcinoma., Histopathology, 75, p. 672, DOI: 10.1111/his.13944 25 10.1111/his.13944 false true Reference 42133700 /api/reference/42133700 26. Mosconi 2019: Immune microenvironment and evasion mechanisms in adenoid cystic carcinomas of salivary glands., Oral Oncol, 88, p. 95, DOI: 10.1016/j.oraloncology.2018.11.028 26 10.1016/j.oraloncology.2018.11.028 false true Reference 42133701 /api/reference/42133701 27. Hendry 2018: Comparison of four PD-L1 immunohistochemical assays in lung cancer., J Thorac Oncol, 13, p. 367, DOI: 10.1016/j.jtho.2017.11.112 27 10.1016/j.jtho.2017.11.112 false true Reference 42133702 /api/reference/42133702 28. Peng 2023: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer., Front Oncol, 13, p. 1011810, DOI: 10.3389/fonc.2023.1011810 28 10.3389/fonc.2023.1011810 false true Reference 42133703 /api/reference/42133703 29. Shah 2022: Association between survival and very high versus high PD-L1 expression in patients receiving pembrolizumab as first-line treatment for advanced non-small cell lung cancer., Clin Lung Cancer, 23, p. 731, DOI: 10.1016/j.cllc.2022.07.003 29 10.1016/j.cllc.2022.07.003 false true Reference 42133704 /api/reference/42133704 30. Stinchcombe 2023: Narrative review: Blood and tumor biomarker testing in non-small cell lung cancer without an oncogenic driver., Transl Lung Cancer Res, 12, p. 158, DOI: 10.21037/tlcr-22-530 30 10.21037/tlcr-22-530 false true Reference 42133705 /api/reference/42133705 31. Wankhede 2022: PD-1/PD-L1 inhibitors in treatment-naïve, advanced non-small cell lung cancer patients with &lt; 1% PD-L1 expression: A meta-analysis of randomized controlled trials., J Cancer Res Clin Oncol, 149, p. 2179, DOI: 10.1007/s00432-022-04286-6 31 10.1007/s00432-022-04286-6 false true Reference 42133706 /api/reference/42133706 32. Chevallier 2021: Oncogenic driver mutations in non-small cell lung cancer: Past, present and future., World J Clin Oncol, 12, p. 217, DOI: 10.5306/wjco.v12.i4.217 32 10.5306/wjco.v12.i4.217 false true Reference 42133707 /api/reference/42133707 33. Lang 2022: Clinical and prognostic implications of CD47 and PD-L1 expression in surgically resected small-cell lung cancer., ESMO Open, 7, p. 100631, DOI: 10.1016/j.esmoop.2022.100631 33 10.1016/j.esmoop.2022.100631 false true Reference 42133708 /api/reference/42133708 34. Qi 2022: Prognostic implications of molecular subtypes in primary small cell lung cancer and Their correlation with cancer immunity., Front Oncol, 12, p. 779276, DOI: 10.3389/fonc.2022.779276 34 10.3389/fonc.2022.779276 false true Reference 42133709 /api/reference/42133709 35. de Sousa 2022: Metastatic adenoid cystic carcinoma: Genomic landscape and emerging treatments., Curr Treat Options Oncol, 23, p. 1135, DOI: 10.1007/s11864-022-01001-y 35 10.1007/s11864-022-01001-y false true /api/publication/33999222 Gyulai Marton et al. PD-1 and PD-L1 expression in rare lung tumors. (2023) PATHOLOGY AND ONCOLOGY RESEARCH 1219-4956 1532-2807 29<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10088166"><a href="/gui2/?type=authors&mode=browse&sel=10088166" target="_blank">Gyulai Marton (<span class="authorship-author-name">Gyulai Márton</span> <span class="authorAux-mtmt"> tüdőgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/Doktori Iskola</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10071898"><a href="/gui2/?type=authors&mode=browse&sel=10071898" target="_blank">Megyesfalvi Zsolt (<span class="authorship-author-name">Megyesfalvi Zsolt</span> <span class="authorAux-mtmt"> Orvostudomány</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Mellkassebészeti Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10025104"><a href="/gui2/?type=authors&mode=browse&sel=10025104" target="_blank">Reiniger Lilla (<span class="authorship-author-name">Reiniger Lilla</span> <span class="authorAux-mtmt"> Neuropatológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Patológiai és Kísérleti Rákkutató Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Harko Tunde </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10077112"><a href="/gui2/?type=authors&mode=browse&sel=10077112" target="_blank">Ferencz Bence (<span class="authorship-author-name">Ferencz Bence</span> <span class="authorAux-mtmt"> Patológia</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Mellkassebészeti Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Karsko Luca </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10051707"><a href="/gui2/?type=authors&mode=browse&sel=10051707" target="_blank">Agocs Laszlo (<span class="authorship-author-name">Agócs László</span> <span class="authorAux-mtmt"> Mellkassebészet</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Mellkassebészeti Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10023823"><a href="/gui2/?type=authors&mode=browse&sel=10023823" target="_blank">Fillinger Janos (<span class="authorship-author-name">Fillinger János</span> <span class="authorAux-mtmt"> patológia</span>) </a> </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10000046"><a href="/gui2/?type=authors&mode=browse&sel=10000046" target="_blank">Dome Balazs (<span class="authorship-author-name">Döme Balázs</span> <span class="authorAux-mtmt"> Tumor indukált angiogenezis</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Mellkassebészeti Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10068108"><a href="/gui2/?type=authors&mode=browse&sel=10068108" target="_blank">Szallasi Zoltan (<span class="authorship-author-name">Szállási Zoltán</span> <span class="authorAux-mtmt"> Onkológia, daganatkutatás</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Bioinformatika Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10003072"><a href="/gui2/?type=authors&mode=browse&sel=10003072" target="_blank">Moldvay Judit ✉ (<span class="authorship-author-name">Moldvay Judit</span> <span class="authorAux-mtmt"> Tüdõgyógyászat</span>) </a> </span> <span class="author-affil">Országos Korányi Pulmonológiai Intézet</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;33999222" target="_blank">PD-1 and PD-L1 expression in rare lung tumors</a></div> <div> <span class="journal-title">PATHOLOGY AND ONCOLOGY RESEARCH</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1219-4956">1219-4956</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1532-2807">1532-2807</a>)</span>: <span class="journal-volume">29</span> <span class="page"> Paper 1611164. 9 p. </span> <span class="year">(2023)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.3389/pore.2023.1611164" target="_blank" href="https://doi.org/10.3389/pore.2023.1611164"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001000102700001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001000102700001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85160982518" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85160982518"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="37274772" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37274772&dopt=Abstract"> PubMed </a> </span> <span class="id identifier oa_NONE" title=" Nincs "> <a style="color:blue" title="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85160982518&doi=10.3389%2Fpore.2023.1611164&partnerID=40&md5=efe8ce91e956272954d7fb703d919ae7" target="_blank" href="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85160982518&doi=10.3389%2Fpore.2023.1611164&partnerID=40&md5=efe8ce91e956272954d7fb703d919ae7"> Egyéb URL </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Oncology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Pathology and Forensic Medicine&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Cancer Research&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q3</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 5</span> | Független: 5 | Függő: 0 | Nem jelölt: 0 | WoS jelölt: 5 | Scopus jelölt:&nbsp;4 | WoS/Scopus jelölt:&nbsp;5 | DOI jelölt:&nbsp;4 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;33999222&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 5 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 33999222</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> (ÚNKP-20-3), (UNKP-21-3), (Hungarian Respiratory Society (MPA #2020)), Az orvos-, egészségtudományi- és gyógyszerészképzés tudományos műhelyeinek fejlesztése(EFOP-3.6.3-VEKOP-16-2017-00009) Támogató: EFOP-VEKOP, (KH130356), (K129065), (KNN121510), (K129065), Hungarian National Brain Research Program(2017-1.2.1-NKP-2017-00002) </div> <div class="lastModified">Utolsó módosítás: 2026.01.06. 09:31 Wolf György (MTMT Központi admin) </div> <div class="lockedBy">Központi kezelésű 2023.10.04. 09:54 Kovács Marcell (MTMT Közp., admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: Funding Agency and Grant Number: Ministry for Innovation and Technology of Hungary; Hungarian Respiratory Society [UNKP-20-3, UNKP-21-3]; IASLC/ILCF Young Investigator Grant [2020]; Semmelweis 250+ Excellence PhD Scholarship by Semmelweis University; Hungarian National Research, Development and Innovation Office [EFOP-3.6.3-VEKOP-16-2017-00009]; Austrian Science Fund [KH130356, K129065, KNN1215...</pre> </div></div>